|
 White House trade adviser Peter Navarro appeared on CNN on Tuesday morning for yet another off-the-rails interview, this time devoting much of his energy to promoting anti-malarial drug hydroxychloroquine following a disputed new study finding some efficacy in treating the coronavirus.Last week, in the wake of the Food and Drug Administration revoking the emergency use of hydroxychloroquine due to serious safety issues and lack of benefit for COVID-19 patients, a Michigan study found the Trump-touted drug helped patients survive from the virus. The findings, however, were quickly disputed by other experts, who noted that the study excluded a large number of patients who hadn't yet been discharged from the hospital.Appearing on CNN's New Day, Navarro quickly brushed off a series of questions from anchor John Berman about the rapid surge of new coronavirus cases in several states, immediately hyping hydroxychloroquine as a game-changer that can greatly reduce mortality rates.Navarro would go on and claim that the reason the United States is experiencing rising cases is because of high asymptomatic spread, ignoring the rising hospitalizations and the fact that other developed countries are experiencing rapid decreases in confirmed cases. At the same time, the Trump aide kept referring to the disease as the "China virus" while pivoting to his favorite malaria drug."Peter, I promise to get to hydroxychloroquine," Berman noted at one point, attempting to
|
|
Private Label